The Effect of Alpha-lactalbumin on Microbiota Composition

Lo.Li.Pharma

Status: Completed

Conditions: Dysbiosis; Alpha-lactalbumin; Microbiota

Treatments: Dietary Supplement: Alpha-lactalbumin

Study type: Interventional

Funder types: Industry

Identifiers

NCT05674318

PREBIO_LAC22

Details and patient eligibility

About

To evaluate the effects on microbiota composition after the administration of an oral supplementation based on Alpha-lactalbumin in subjects with dysbiosis.

Enrollment: 10 patients

Sex: All

Ages: 25 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• condition of dysbiosis

Exclusion criteria

• antibiotic treatment within 1 month
• probiotic or prebiotic treatments
• concomitant inflammatory intestinal diseases
• pregnancy
• neoplastic diseases
• allergy to milk protein (Alpha-lactalbumin)
• substance abuse

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

Alpha-lactalbumin

Experimental group

Treatment:

Dietary Supplement: Alpha-lactalbumin